Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Mei Pharma Inc (NQ: MEIP )

2.770 USD -0.080 (-2.80%)
Streaming Delayed Price Updated: 3:17 PM EDT, Oct 26, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 234,982
Open 2.850
Bid (Size) 2.770 (17)
Ask (Size) 2.780 (22)
Prev. Close 2.850
Today's Range 2.720 - 2.890
52wk Range 0.7200 - 4.460
Shares Outstanding 70,326,737
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lifshitz Law Firm, P.C. Announces Investigation of Cognizant Technology Solutions Corporation, Honeywell International Inc., MEI Pharma, Inc., Nikola Corporation, The Chemours Company and YayYo, Inc.
From PR Newswire
SHAREHOLDER ALERT FILING DEADLINE: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – MEIP
From GlobeNewswire News Releases

Performance

YTD
+15.42%
+15.42%
1 Month
-11.21%
-11.21%
3 Month
-7.04%
-7.04%
6 Month
+11.70%
+11.70%
1 Year
+56.50%
+56.50%

More News

Read More
MEIP FINAL DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important Friday Deadline in Securities Class Action - MEIP
From PR Newswire
Shareholder Alert: Robbins LLP Reminds Investors MEI Pharma, Inc. (MEIP) Accused of Misleading Shareholders
From Business Wire News Releases
Portnoy Law: October 9th Deadline Alert in Lawsuit Filed On Behalf of MEI Pharma, Inc. Investors
From GlobeNewswire News Releases
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action – MEIP
From GlobeNewswire News Releases
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
From PR Newswire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc. and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – MEIP
From GlobeNewswire News Releases
MEI Pharma Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MEI Pharma, Inc. To Contact The Firm
From NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X